药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Bilastine.
19-Nor-4-androstenedione
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Bilastine.
19-Nor-4-androstenedione
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Bilastine.
19-Nor-4-androstenedione
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Bilastine.
19-Nor-4-androstenedione
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Bilastine.
19-Nor-4-androstenedione
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Bilastine.
19-Nor-4-androstenedione
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Bilastine.
19-Nor-4-androstenedione
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Bilastine.
19-Nor-4-androstenedione
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Bilastine.
19-Nor-4-androstenedione
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Bilastine.
19-Nor-4-androstenedione
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Bilastine.
19-Nor-4-androstenedione
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Bilastine.
19-Nor-4-androstenedione
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Bilastine.
19-Nor-4-androstenedione
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Bilastine.
19-Nor-4-androstenedione
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Bilastine.
19-Nor-4-androstenedione
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Bilastine.
19-Nor-4-androstenedione
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Bilastine.
19-Nor-4-androstenedione
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Bilastine.
19-Nor-4-androstenedione
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Bilastine.
19-Nor-4-androstenedione
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Bilastine.